# The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT

> **NCT05944445** · — · UNKNOWN · sponsor: **Helwan University** · enrollment: 310 (estimated)

## Conditions studied

- Thrombocytopenia; Drugs

## Interventions

- **DRUG:** Linezolid 600 mg

## Key facts

- **NCT ID:** NCT05944445
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-13
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2023-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944445, "The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05944445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*